The dysregulation of WNT signalling cascade in tumorigenesis has been well documented and WNT antagonists sFRP3, DKK3 and WIF1 are frequently downregulated in BC contributing to constitutive activation of oncogenic growth factors35. The gene discussed is FRZB; the disease is breast cancer.